-
Single-cell characterization of anti-LAG3+anti-PD1 treatment in melanoma patients
Study
EGAS00001005580
-
Berlin Neuroblastoma Dataset Update 2021
Study
EGAS00001005604
-
PIK3CA mutation in a case of CTNNB1 mutant sinonasal glomangiopericytoma
Study
EGAS00001005653
-
Myeloma methylation
Study
EGAS00001005788
-
Mutations in ALK signaling pathways conferring resistance to ALK inhibitor treatment lead to collateral vulnerabilities in neuroblastoma cells
Study
EGAS00001005791
-
RNA-seq data from 27 glioblastoma samples
Study
EGAS00001005807
-
Orthotopic murine Group 3 medulloblastoma in C57Bl/6 mice treated with saline, cyclophosphamide or gemcitabine
Study
EGAS00001005846
-
Orthotopic murine Group 3 medulloblastoma in C57Bl/6 mice treated with sham or craniospinal irradiation
Study
EGAS00001005847
-
Overexpression of the miR-17-92 cluster in colorectal adenoma organoids induces a carcinoma-like genotype
Study
EGAS00001005949
-
Oesophageal adenocarcinoma whole exome and RNA-seq raw sequencing data
Study
EGAS00001005957
-
Targeted analysis of cell-free circulating tumor DNA is suitable for early relapse and actionable target detection in patients with neuroblastoma
Study
EGAS00001006027
-
A multi-center genome-wide association study for nasopharyngeal carcinoma
Study
EGAS00001006062
-
Molecular characterization of a renal cell carcinoma PDX cohort
Study
EGAS00001006249
-
Genomic profiling of metastatic basal cell carcinoma reveals candidate drivers of disease and therapeutic targets
Study
EGAS00001006148
-
Validation of a targeted sequencing panel for multiple myeloma
Study
EGAS00001006164
-
Study of the microenvironment of angioimmunoblastic T-cell lymphoma
Study
EGAS00001006401
-
A Risk Score Incorporating Low Pass Whole Genome Sequencing of Cell Free DNA from Patients Receiving CD19 CAR T-Cell Therapy for Large B-Cell Lymphoma
Study
EGAS00001006308
-
Molecular determinants of outcomes in relapsed mantle cell lymphoma treated with ibrutinib or temsirolimus in the MCL3001 (RAY) trial
Study
EGAS00001006342
-
Soft tissue sarcoma sequencing data
Study
EGAS00001006356
-
Single-cell study of 14 childhood medulloblastoma patients
Study
EGAS00001006392
-
Quantitative Exploratory Proteomics Analysis of Glioblastoma in Initial and Recurrent Tumors
Study
EGAS00001006395
-
Case Report: early contribution of germline and nevi genetic alterations to a rapidly-progressing Cutaneous Melanoma Patient
Study
EGAS00001006459
-
microRNA and isomiR profiling of Stage 1 epithelial ovarian carcinoma
Study
EGAS00001006617
-
TK-EPN862 - Patient-dervied xenograft model of Posterior Fossa A Ependymoma - WGS
Study
EGAS00001006843
-
Genomic Analysis of a Metastatic Fusion-negative Embryonal Rhabdomyosarcoma
Study
EGAS00001006946
-
Germline variants in childhood cutaneous melanoma
Study
EGAS00001006995
-
Whole genome, RNA-seq and single-cell Multiome profile of multiple myeloma
Study
EGAS00001007014
-
VRK3 depletion in Pontine Diffuse Midline Glioma (DMG)-K27 altered cells
Study
EGAS00001007047
-
Genomic Landscape of Follicular Lymphoma Across a Wide Spectrum of Clinical Behaviors
Study
EGAS00001007105
-
TIGIT is the central player in T-cell suppression associated with CAR T-cell relapse in mantle cell lymphoma
Study
EGAS00001007113
-
Exploration of neuroblastoma xenograft models for tumor extracellular RNA profiling in murine blood plasma
Study
EGAS00001007295
-
Detection of somatic mutations of angioimmunoblastic T-cell lymphoma
Study
EGAS00001007333
-
Integrative genomic analyses of European intrahepatic cholangiocarcinoma: new ROS1 fusion gene and PBX1 as prognostic marker
Study
EGAS00001007525
-
Identification of Novel Immunotherapy Targets in Myeloma
Study
phs003772
-
Single-cell Analysis of Neoplastic Plasma Cells Identifies Novel Myeloma Pathobiology Mediators and Potential Targets
Study
EGAS50000000801
-
Single-cell Analysis of Neoplastic Plasma Cells Identifies Myeloma Pathobiology Mediators and Potential Targets
Study
EGAS50000000802
-
Single-cell Analysis of Neoplastic Plasma Cells Identifies Novel Myeloma Pathobiology Mediators and Potential Targets
Study
EGAS50000000803
-
WGS of Newly Diagnosed and Refractory/Relapsed Multiple Myeloma
Dataset
EGAD50000001177
-
The function of LAMP5 in multiple myeloma
Dataset
EGAD50000001178
-
Single-cell Transcriptome Analysis of Plasma Cells Across the Disease Spectrum of Multiple Myeloma
Dataset
EGAD50000001179
-
MDACC Lymphoma & Myeloma WGS of Tumor and Non-tumor Cells in Multiple Myeloma
Dac
EGAC50000000282
-
MDACC Lymphoma & Myeloma The function of LAMP5 in multiple myeloma
Dac
EGAC50000000495
-
MDACC Lymphoma & Myeloma scRNAseq of Plasma Cells in Multiple Myeloma
Dac
EGAC50000000271
-
TRACERx NSCLC - whole genome sequencing for ctDNA study
Study
EGAS50000000313
-
Peripheral T cell lymphoma (PTCL) Shallow Whole Genome Sequencing
Dataset
EGAD50000001146
-
metastatic uveal melanoma tumour biopsies
Study
EGAS50000000864
-
mUM patient biopsies pre and post treatment with tebentafusp
Dataset
EGAD50000001258
-
International Cancer Proteogenome Consortium (ICPC): Proteogenomics of Oral Squamous Cell Carcinoma in Taiwan
Study
phs002580
-
A neoadjuvant, phase II trial demonstrates efficacy and tolerability of Talimogene laherparepvec in cutaneous basal cell carcinoma (NeoBCC trial)
Study
EGAS50000000252
-
Epigenetic landscape reorganization and reactivation of embryonic development genes are associated with malignancy in IDH-mutant astrocytoma
Study
EGAS50000000381